Isakova, Tamara

FGF23 induces left ventricular hypertrophy

Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation

Parathyroid Disorders and TreatmentsCardiac Fibrosis and Remodeling

Cited by 2,027

DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease

Dussold, C., Gerber, C., White, S., Wang, X., Qi, L., Francis, C., Capella, M., Courbon, G., Wang, J., Li, C., et al. (2019) · Bone Research

Parathyroid Disorders and TreatmentsBone Metabolism and Diseases

Cited by 96

Effects of TZD use and discontinuation on fracture rates in ACCORD bone study

Schwartz, A. V., Chen, H., Ambrosius, W. T., Sood, A., Josse, R. G., Bonds, D. E., Schnall, A. M., Vittinghoff, E., Bauer, D. C., Banerji, M. A., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism

Bone health and osteoporosis researchDiabetes Treatment and Management

Cited by 85

Associations of Fenofibrate Therapy With Incidence and Progression of CKD in Patients With Type 2 Diabetes

Frazier, R., Mehta, R., Cai, X., Lee, J., Napoli, S., Craven, T., Tuazon, J., Safdi, A., Scialla, J., Susztak, K., et al. (2019) · Kidney International Reports

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 63